These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24676208)

  • 1. Association between antibody titers and protection against influenza virus infection within households.
    Tsang TK; Cauchemez S; Perera RA; Freeman G; Fang VJ; Ip DK; Leung GM; Malik Peiris JS; Cowling BJ
    J Infect Dis; 2014 Sep; 210(5):684-92. PubMed ID: 24676208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children.
    Verschoor CP; Singh P; Russell ML; Bowdish DM; Brewer A; Cyr L; Ward BJ; Loeb M
    PLoS One; 2015; 10(6):e0131531. PubMed ID: 26107625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
    Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
    Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.
    Petrie JG; Martin ET; Truscon R; Johnson E; Cheng CK; McSpadden EJ; Malosh RE; Lauring AS; Lamerato LE; Eichelberger MC; Ferdinands JM; Monto AS
    Vaccine; 2019 Feb; 37(10):1284-1292. PubMed ID: 30738647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.
    Morrison BJ; Martin NJ; Rehman T; Ewing D; Dewar RL; Metcalf J; Sun P; Beigel J; Luke TC; Raviprakash K
    BMC Health Serv Res; 2018 Aug; 18(1):651. PubMed ID: 30134892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay.
    Li ZN; Liu F; Gross FL; Kim L; Ferdinands J; Carney P; Chang J; Stevens J; Tumpey T; Levine MZ
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection.
    Fox A; Mai le Q; Thanh le T; Wolbers M; Le Khanh Hang N; Thai PQ; Thi Thu Yen N; Minh Hoa le N; Bryant JE; Duong TN; Thoang DD; Barr IG; Wertheim H; Farrar J; Hien NT; Horby P
    J Infect; 2015 Feb; 70(2):187-96. PubMed ID: 25224643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.
    Ng S; Saborio S; Kuan G; Gresh L; Sanchez N; Ojeda S; Harris E; Balmaseda A; Gordon A
    Vaccine; 2017 Oct; 35(45):6202-6207. PubMed ID: 28986036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents.
    Wang B; Russell ML; Brewer A; Newton J; Singh P; Ward BJ; Loeb M
    Influenza Other Respir Viruses; 2017 May; 11(3):283-288. PubMed ID: 28218983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Preseason Antibodies Against Influenza Virus on Risk of Influenza Infection Among Healthcare Personnel.
    Gorse GJ; Rattigan SM; Kirpich A; Simberkoff MS; Bessesen MT; Gibert C; Nyquist AC; Price CS; Gaydos CA; Radonovich LJ; Perl TM; Rodriguez-Barradas MC; Cummings DAT
    J Infect Dis; 2022 Mar; 225(5):891-902. PubMed ID: 34534319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children.
    Ng S; Fang VJ; Ip DK; Chan KH; Leung GM; Peiris JS; Cowling BJ
    J Infect Dis; 2013 Oct; 208(8):1320-4. PubMed ID: 23908481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal Antibodies Against Influenza in Cord Blood and Protection Against Laboratory-Confirmed Influenza in Infants.
    Cowling BJ; Perera RAPM; Fang VJ; Chu DKW; Hui APW; Yeung APC; Peiris JSM; Wong WHS; Chan ELY; Chiu SS
    Clin Infect Dis; 2020 Oct; 71(7):1741-1748. PubMed ID: 31665236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low seroprotection against preseasonal influenza local strains in children might predict the upcoming epidemic influenza strains.
    Su WJ; Shao PL; Liu MT; Liu DP; Huang KC; Chang LY; Lu CY; Wang JR; Shih SR; Huang DT; Chi H; Huang LM
    Clin Infect Dis; 2010 Jul; 51(2):171-6. PubMed ID: 20528478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring antibody responses to a live attenuated influenza vaccine in children.
    Lee MS; Mahmood K; Adhikary L; August MJ; Cordova J; Cho I; Kemble G; Reisinger K; Walker RE; Mendelman PM
    Pediatr Infect Dis J; 2004 Sep; 23(9):852-6. PubMed ID: 15361726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.
    Memoli MJ; Shaw PA; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Fargis S; Risos K; Powers JH; Davey RT; Taubenberger JK
    mBio; 2016 Apr; 7(2):e00417-16. PubMed ID: 27094330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza B.
    Cowling BJ; Lim WW; Perera RAPM; Fang VJ; Leung GM; Peiris JSM; Tchetgen Tchetgen EJ
    Clin Infect Dis; 2019 May; 68(10):1713-1717. PubMed ID: 30202873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.
    Co MD; Terajima M; Thomas SJ; Jarman RG; Rungrojcharoenkit K; Fernandez S; Yoon IK; Buddhari D; Cruz J; Ennis FA
    Viral Immunol; 2014 Oct; 27(8):375-82. PubMed ID: 25141276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.